Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X-ray photon absorption by iodine-containing tissues refers to the markedly increased attenuation of X-ray photons in tissues with elevated atomic number elements, particularly iodine. When iodinated contrast media are administered, they accumulate in specific tissues or vascular compartments, thus increasing local X-ray absorption through the photoelectric effect. This heightened absorption is especially pronounced at photon energies near the iodine K-edge (33.2 keV). This property is exploited in diagnostic radiology (e.g., CT scans, angiography) to create image contrast between iodine-rich and iodine-poor areas, enabling improved visualization of anatomical structures and pathological findings. This is a physical and chemical principle utilized in imaging protocols, not a biological or pharmacological target[1][2][3].
Enhanced X-ray attenuation via increased photoelectric absorption at the iodine K-edge (around 33.2 keV), leading to improved soft tissue contrast on radiographic/CT images[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-ray photon absorption by iodine-containing tissues.